And for those who may have missed it in the news, this is the brand name of a relatively new drug, part of the class of semaglutides designed for use in patients with diabetes, gaining in popularity for its off-label use in the general population for the purposes of weight management. It’s known for its ability to decrease the patient’s appetite.

My breezy use of the name of Ozempic here is intended to raise the question: if appetite suppression is what we desire in order to facilitate weight loss (a logical inference), then how might we decrease appetite without drugs? If that question interests you, keep reading.